RMTG Broadens Longevity Footprint With New ISSCA Certification Across Adjunctive Therapies

    169 Aufrufe 169 0 Kommentare 0 Kommentare

    New ISSCA curriculum covers multiple adjunctive technologies used in longevity-focused practices and is intended to complement clinical capabilities Cellular Hope Institute is developing. MIAMI, FL / ACCESS Newswire / October 5, 2026 / Regenerative …

    RMTG Broadens Longevity Footprint With New ISSCA Certification Across Adjunctive Therapies

    New ISSCA curriculum covers multiple adjunctive technologies used in longevity-focused practices and is intended to complement clinical capabilities Cellular Hope Institute is developing.

    MIAMI, FL / ACCESS Newswire / October 5, 2026 / Regenerative Medical Technology Group, Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, today announced a new Longevity and Adjunctive Therapies Certification from its ISSCA division. The program is focused on complementary and adjunctive technologies increasingly discussed in longevity and regenerative medicine practices.

    The curriculum addresses therapeutic plasma exchange, EBOO/EVO, peptide medicine, IV therapy, artificial intelligence tools, PEMF, photobiomodulation, red-light technologies, hyperbaric medicine, and other emerging approaches increasingly incorporated into longevity-focused medical practices. ISSCA indicates the program is designed to help physicians understand how multiple adjunctive technologies may fit within a comprehensive medical practice, rather than certifying any single modality in isolation.

    The certification is among the broader multi-modality curricula currently offered by ISSCA and is intended to complement clinical capabilities that Cellular Hope Institute, the Company's Cancún clinic, is separately evaluating or developing. It does not mean that every technology covered in the curriculum is currently offered, authorized, or available at Cellular Hope Institute.

    Education and Clinical Complement

    David Christensen, Chief Executive Officer and President of Regenerative Medical Technology Group, Inc., commented:

    "Longevity medicine is rapidly moving toward comprehensive programs that combine multiple technologies. Our goal is to position RMTG across that evolution, both in how physicians learn about these therapies and, where permitted, in how related services may be delivered in clinical practice."

    Christensen continued:

    "This program gives ISSCA a broader educational presence in longevity medicine and is designed to complement capabilities we are developing at Cellular Hope Institute."

    The launch expands the range of topics addressed by ISSCA and is intended to align physician education more closely with technologies relevant to the Company's clinical operations. The Company believes this combination may create additional avenues for physician engagement as interest in longevity-focused care continues to develop.

    Seite 1 von 3 






    Verfasst von Accesswire
    RMTG Broadens Longevity Footprint With New ISSCA Certification Across Adjunctive Therapies New ISSCA curriculum covers multiple adjunctive technologies used in longevity-focused practices and is intended to complement clinical capabilities Cellular Hope Institute is developing. MIAMI, FL / ACCESS Newswire / October 5, 2026 / Regenerative …

    Im Durchschnitt erleiden 7 von 10 Kleinanlegern Verluste beim Handel mit Turbo-Zertifikaten. Turbo-Zertifikate sind hoch risikoreiche Produkte und nicht für langfristige Anlagestrategien geeignet.
    Profitieren Sie von unserem Alleinstellungsmerkmal als den zentralen verlagsunabhängigen Wissens-Hub für einen aktuellen und fundierten Zugang in die Börsen- und Wirtschaftswelt, um strategische Entscheidungen zu treffen.
    • ✅ Größte Finanz-Community Deutschlands
    • ✅ über 550.000 registrierte Nutzer
    • ✅ rund 2.000 Beiträge pro Tag
    • ✅ verlagsunabhängige Partner ARIVA, FinanzNachrichten und BörsenNews
    • ✅ Jederzeit einfach handeln beim SMARTBROKER+
    • ✅ mehr als 25 Jahre Marktpräsenz
    Aktien von A - Z: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    wallstreetONLINE bei X wallstreetONLINE bei Instagram wallstreetONLINE bei Facebook wallstreetONLINE bei Youtube wallstreetONLINE bei LinkedIn
    Unsere Apps: Apple App Store Icon Google Play Store Icon
    Wenn Sie Kursdaten, Widgets oder andere Finanzinformationen benötigen, hilft Ihnen ARIVA gerne. 

    Unsere User schätzen wallstreet-online.de: 4.8 von 5 Sternen ermittelt aus 285 Bewertungen bei www.kagels-trading.de
    Zeitverzögerung der Kursdaten: Deutsche Börsen +15 Min. NASDAQ +15 Min. NYSE +20 Min. AMEX +20 Min. Dow Jones +15 Min. Alle Angaben ohne Gewähr.
    Copyright © 1998-2026 Smartbroker Holding AG - Alle Rechte vorbehalten.
    Mit Unterstützung von: Ariva Smartbroker+
    Daten & Kurse von: TTMzero